ethyl 2-(5-(4-chlorophenyl)pentyl)oxiran-2-carboxylate has been researched along with indomethacin in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Schmilinsky-Fluri, G; Valiunas, V; Weingart, R; Willi, M | 1 |
1 other study(ies) available for ethyl 2-(5-(4-chlorophenyl)pentyl)oxiran-2-carboxylate and indomethacin
Article | Year |
---|---|
Modulation of cardiac gap junctions: the mode of action of arachidonic acid.
Topics: Animals; Arachidonic Acid; Cells, Cultured; Cyclooxygenase Inhibitors; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme System; Eicosanoids; Epoxy Compounds; Gap Junctions; Hypoglycemic Agents; Indomethacin; Lipoxygenase; Lipoxygenase Inhibitors; Masoprocol; Myocardium; Oxidation-Reduction; Oxygenases; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Wistar | 1997 |